NCT03981016 (CEREMET-LR) is a NA clinical trial of Biological collection in Central Nervous System Tumor, sponsored by Institut du Cancer de Montpellier - Val d'Aurelle.

Who is sponsoring NCT03981016?

NCT03981016 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle.

What drugs are being tested in NCT03981016?

Interventions in NCT03981016: Biological collection.

What condition does NCT03981016 study?

NCT03981016 studies Central Nervous System Tumor.

Is NCT03981016 still recruiting?

NCT03981016 is currently completed. Last updated 19 October 2020.

Last reviewed 2020-10-19 · How we verify

NCT03981016: CEREMET-LR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medical and Surgical Management of Patients With Brain Metastases

Completed NA Last updated 19 October 2020

What this trial tests

NA trial testing Biological collection in Central Nervous System Tumor in 105 participants. Completed in 31 August 2020.

Timeline

2 March 2015

Primary endpoint
19 January 2018

31 August 2020

Quick facts

Lead sponsor	Institut du Cancer de Montpellier - Val d'Aurelle
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	105
Start date	2 March 2015
Primary completion	19 January 2018
Estimated completion	31 August 2020
Sites	12 locations across France

Drugs / interventions tested

Biological collection — full drug profile →

Conditions studied

Central Nervous System Tumor — all drugs for Central Nervous System Tumor →

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle — full company profile →

Who can join

18 and older, any sex, with Central Nervous System Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The integrated cancer research site (SIRIC) of Montpellier proposes to develop a prospective and regional Clinical Database Project and regional biological collection (blood and tumor samples), which is an expanding data collection designed to contribute to a better understand the patient's management with brain metastases including quality of life and neuropsychological/cognitive aspects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Biological collection

Trials testing the same drug.

NCT07412717 — The Efficacy of Combining Music Intervention With Nicotine Replacement Therapy to Reduce Smoking Craving, Among Healthca · NA · not yet recruiting
NCT05936333 — Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis · NA · recruiting
NCT06018519 — Relevant Outcome Measures for Creatine Transporter Deficiency Patient · NA · recruiting
NCT05088473 — Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases · completed
NCT04103567 — Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers · NA · recruiting

Other recruiting trials for Central Nervous System Tumor

Currently open trials in the same condition.

NCT07378683 — A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery · NA · recruiting
NCT06054295 — Somatic Mosaicism in Twins Discordant for Childhood Cancer · recruiting
NCT06104488 — A Study of Avutometinib for People With Solid Tumor Cancers · Phase 1 · recruiting
NCT05978557 — Brain Slice Explants to Predict Drug Response in Brain Tumors · recruiting
NCT04732065 — ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors · Phase 1 · recruiting

Other Institut du Cancer de Montpellier - Val d'Aurelle trials

Trials by the same sponsor.

NCT07523152 — Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With H · NA · not yet recruiting
NCT07198971 — Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addicti · NA · recruiting
NCT07043543 — Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) · NA · not yet recruiting
NCT07441941 — Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup · recruiting
NCT06382818 — Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03981016 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut du Cancer de Montpellier - Val d'Aurelle
Last refreshed: 19 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03981016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing